A complete BPC-157 dosage and reconstitution guide requires understanding proper peptide math, sterile technique, and correct storage practices. Most research protocols reference dosages between 200–500 mcg administered once or twice daily, with reconstitution performed using bacteriostatic water to preserve peptide stability. Precision in every step — from mixing to injection to disposal — is essential for consistent, reliable research outcomes.
BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has attracted significant attention in peptide research communities for its observed effects on tissue repair, angiogenesis, and modulation of the nitric oxide system. For researchers working with this compound, a complete BPC-157 dosage and reconstitution guide is essential to ensure accurate dosing, maintain compound integrity, and uphold proper laboratory practice throughout the protocol.
This guide walks through every stage of the process — from understanding the peptide’s background and calculating dosages to reconstituting the lyophilized powder, administering injections, and storing the compound between uses. Whether you are new to peptide research or refining an existing protocol, the information below is grounded in the peer-reviewed literature and established best practices within the research community.
Understanding BPC-157: Background and Mechanism
BPC-157 is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that has been studied extensively in animal models since the early 1990s. Research published in journals such as Journal of Physiology – Paris, Life Sciences, and Current Pharmaceutical Design has documented its potential involvement in accelerating tendon, ligament, muscle, and intestinal tissue healing. The peptide appears to operate through multiple pathways, including upregulation of growth factor expression (particularly VEGF and EGF), modulation of the NO system, and interaction with the dopaminergic and serotonergic systems.
It is important to note that the vast majority of BPC-157 research has been conducted in rodent models. While the results are compelling, human clinical trial data remains extremely limited. All dosing references in this article are derived from animal study extrapolations and anecdotal research community protocols, not from approved clinical guidelines.
BPC-157 Dosage Protocols: What the Research Suggests
Dosing in animal studies is typically reported as micrograms per kilogram of body weight (mcg/kg). The most commonly cited range in rodent studies is 10 mcg/kg, though some protocols use doses as low as 1 mcg/kg or as high as 50 mcg/kg. When researchers extrapolate these figures for human-equivalent dosing (using standard allometric scaling), the commonly referenced range falls between 200 mcg and 800 mcg per day, with the majority of community protocols clustering around 250–500 mcg administered once or twice daily.
| Body Weight Range | Conservative Dose (once daily) | Standard Dose (once daily) | Higher Dose (twice daily) | Typical Protocol Duration |
|---|---|---|---|---|
| Under 70 kg (154 lbs) | 200 mcg | 250 mcg | 250 mcg x 2 | 4–6 weeks |
| 70–90 kg (154–198 lbs) | 250 mcg | 300–500 mcg | 250–500 mcg x 2 | 4–6 weeks |
| Over 90 kg (198 lbs) | 300 mcg | 500 mcg | 500 mcg x 2 | 4–8 weeks |
Most research protocols suggest subcutaneous injection as the primary administration route, with the injection site chosen for proximity to the area of interest (e.g., near an injured tendon or joint). Some protocols reference intramuscular injection or even oral administration, though subcutaneous remains the most widely documented. Protocol lengths typically range from 4 to 8 weeks, with some researchers incorporating a brief off-period before repeating.
Step-by-Step Reconstitution Guide
BPC-157 is supplied as a lyophilized (freeze-dried) powder in a sealed glass vial, most commonly in quantities of 5 mg. The reconstitution process involves dissolving this powder into a sterile liquid to create an injectable solution. Precision and sterile technique during this step are critical to both peptide viability and research safety.
Step 1: Gather Your Supplies. You will need the BPC-157 vial, a vial of bacteriostatic water (BAC water preserved with 0.9% benzyl alcohol), insulin syringes (typically 1 mL / 100 unit U-100), and alcohol prep pads for sanitizing vial stoppers and injection sites.
Step 2: Determine Your Reconstitution Volume. The amount of bacteriostatic water you add dictates the concentration of the resulting solution. This is the most important calculation in the entire process. Use the following formula:
Concentration (mcg per unit) = Total peptide (mcg) ÷ Total units of water added
| Bacteriostatic Water Added | Resulting Concentration (per 5 mg vial) | Volume for 250 mcg Dose | Volume for 500 mcg Dose |
|---|---|---|---|
| 1 mL (100 units) | 50 mcg per unit | 5 units | 10 units |
| 2 mL (200 units) | 25 mcg per unit | 10 units | 20 units |
| 2.5 mL (250 units) | 20 mcg per unit | 12.5 units | 25 units |
Many researchers prefer adding 2 mL of bacteriostatic water to a 5 mg vial, yielding a concentration of 25 mcg per unit on a standard insulin syringe. This provides a good balance between dose precision and injectable volume.
Step 3: Reconstitute the Peptide. Wipe the tops of both the BPC-157 vial and the bacteriostatic water vial with alcohol prep pads. Draw the desired amount of BAC water into an insulin syringe. Insert the needle into the BPC-157 vial and slowly inject the water down the inside wall of the vial — never spray it directly onto the powder, as this can damage the peptide chains. Allow the powder to dissolve naturally; do not shake the vial. Gentle swirling is acceptable if needed after a minute or two.
Step 4: Store the Reconstituted Peptide. Once reconstituted, BPC-157 should be stored in a refrigerator at 2–8°C (36–46°F). A dedicated peptide storage case or mini fridge helps maintain consistent temperature and protects the vial from light exposure. Reconstituted BPC-157 in bacteriostatic water typically remains stable for 28–30 days under proper refrigeration.
What You Will Need
Before beginning this protocol, researchers typically gather the following supplies: bacteriostatic water for reconstitution, insulin syringes for precise measurement (29- or 31-gauge are standard for subcutaneous injection), alcohol prep pads for sterile technique, and a sharps container for safe disposal of used needles. Proper peptide storage cases or a dedicated mini fridge help maintain compound integrity between uses. Having all supplies prepared in advance ensures a smooth, uncontaminated reconstitution and injection process.
Administration and Injection Protocol
Once the peptide is reconstituted, draw the appropriate dose into a fresh insulin syringe. Common subcutaneous injection sites include the lower abdomen (avoiding the navel area), the fatty tissue above the hip, or near the site of the tissue being researched. Clean the injection site thoroughly with an alcohol prep pad and allow it to dry for a few seconds before inserting the needle at a 45-degree angle. Inject slowly, withdraw the needle, and dispose of it immediately in a sharps container — never recap or reuse needles.
Researchers often administer BPC-157 on an empty stomach or at least 30 minutes before eating, as some evidence suggests improved absorption under fasting conditions. For protocols involving twice-daily dosing, morning and evening injections spaced approximately 12 hours apart are typical.
Supporting Recovery: Complementary Practices
Researchers investigating BPC-157 for tissue repair often combine the peptide protocol with complementary recovery strategies to create a more comprehensive research framework. Omega-3 fish oil supplementation is widely documented for its role in modulating inflammatory pathways and supporting cellular membrane health, making it a natural companion to peptide research focused on healing. Similarly, magnesium glycinate — a highly bioavailable form of magnesium — is commonly used to support sleep quality, muscle relaxation, and recovery, all of which are relevant when the body is undergoing tissue repair processes.
Red light therapy (photobiomodulation) has gained traction in research circles as a modality that may enhance mitochondrial function and accelerate tissue healing. Some researchers pair it with BPC-157 protocols to explore potential synergistic effects on tendon and soft tissue recovery. Physical recovery tools like a foam roller or massage gun can also support blood flow to targeted areas, potentially complementing the angiogenic properties observed in BPC-157 studies.
Track your peptide protocol
Log every dose, cost, and observation in one organized spreadsheet.
Complementary Research Tools and Supplements
Beyond the core reconstitution and injection supplies, many researchers incorporate additional tools to support overall health during peptide protocols. Vitamin D3 plays a well-established role in immune regulation and has been linked to improved tissue repair outcomes in several studies — maintaining adequate levels is considered foundational. NMN (nicotinamide mononucleotide), a precursor to NAD+, has emerged as a compound of interest for supporting cellular energy and repair mechanisms, and some researchers explore it alongside peptide protocols to investigate effects on overall recovery and cellular resilience. For researchers managing stress and cortisol levels — which can impair healing — ashwagandha is frequently referenced as an adaptogen with a meaningful body of evidence supporting its role in stress modulation.
Common Mistakes to Avoid
Even experienced researchers can encounter issues that compromise their BPC-157 protocol. Avoid these common pitfalls:
Spraying water directly onto the lyophilized powder. This high-pressure stream can break peptide bonds and degrade the compound. Always aim the stream against the glass wall of the vial.
Using sterile water instead of bacteriostatic water. Plain sterile water lacks a preservative, meaning the reconstituted solution must be used within 24 hours. Bacteriostatic water extends shelf life to approximately 28–30 days.
Storing reconstituted peptides at room temperature. Heat and light degrade peptides rapidly. Always refrigerate after reconstitution.
Reusing or sharing syringes. This introduces contamination risk. Use a new insulin syringe for every injection and dispose of it properly in a sharps container.
Incorrect dosage math. Double-check your reconstitution volume and corresponding unit measurements before every injection. The tables above should serve as a reliable reference.
Frequently Asked Questions
Q: How long does reconstituted BPC-157 last in the refrigerator?
A: When reconstituted with bacteriostatic water and stored at 2–8°C in a refrigerator or dedicated peptide storage case, BPC-157 typically remains stable for approximately 28–30 days. If reconstituted with plain sterile water (without benzyl alcohol preservative), it should be used within 24 hours.
Q: Can BPC-157 be taken orally instead of injected?
A: Some research protocols and animal studies have explored oral administration of BPC-157, particularly for gastrointestinal research applications. The peptide has demonstrated notable stability in gastric acid compared to other peptides. However, subcutaneous injection remains the most commonly documented route for systemic or localized tissue research, as it bypasses digestive degradation and allows for more precise dosing.
Q: What is the difference between subcutaneous and intramuscular injection for BPC-157?
A: Subcutaneous injection delivers the peptide into the fatty tissue just beneath the skin, while intramuscular injection places it deeper into muscle tissue. Subcutaneous is the more common route in BPC-157 research due to its simplicity and slower absorption profile. Some researchers choose injection sites near the area of interest, though the peptide’s systemic effects have been observed regardless of injection location in animal studies.
Q: Are there any known side effects of BPC-157 in the existing literature?
A: Animal studies on BPC-157 have reported a remarkably favorable safety profile, with no significant toxicity observed even at high doses. However, the absence of comprehensive human clinical trials means that a complete side effect profile has not been established. Researchers should approach any peptide protocol with appropriate caution and documentation.
This article is for research and informational purposes only. Nothing on PepStackHQ constitutes medical advice. Consult a qualified healthcare professional before beginning any research protocol.